Dr. Rabab Tayyem is the Executive Director and CEO of ACDIMA BioCenter. She has a BSc in Pharmacy in addition to MSc in Analytical Toxicology and obtained her postgraduate PhD degree in Drug Design and Medicinal Chemistry. Dr. Tayyem has more than 20-year experience in clinical and bioequivalence studies, after starting her career in pharmaceutical industry. Working in ACDIMA BioCenter for more than 17 years she culminated the experience from start and worked in different functions articulated in the core of regulatory sciences related to bioequivalence and bioavailability studies.